Keynote Speakers

Dr. Gyorgy Abel

Dr. Gyorgy Abel

Medical Director of the Molecular Diagnostics and Clinical Immunology Laboratories and Point of Care Testing, Lahey Hospital & Medical Center, Beth Israel Lahey Health
Instructor in Pathology, Part-time, Harvard Medical School

| KEYNOTE LECTURE

Global Trends in Point of Care Diagnostics: New Opportunities and Challenges 

Biography

Gyorgy Abel, MD, PhD is Medical Director of the Molecular Diagnostics and Clinical Immunology Laboratories and Point of Care Testing at Lahey Hospital & Medical Center, Beth Israel Lahey Health. He also serves as Instructor in Pathology, Part-time, at Harvard Medical School. Gyorgy received his M.D. and a Ph.D. in immunology in Hungary. He completed post-doctoral fellowship at the Brigham and Women’s Hospital and clinical pathology residency at the Massachusetts General Hospital in Boston, USA. His lab was among the firsts to develop a diagnostic PCR for HCV and was first in the U.S. to offer the 20-minute LIAT IVD rapid PCR test clinically for influenza A/B.  Gyorgy has held office in professional organizations such as the American Association for Clinical Chemistry (AACC), the College of American Pathologists, and the American Association of Immunologists. He is the immediate Past-president of the AACC Academy. He authored or co-authored 65 publications and gave over 100 scientific presentations.

Dr. Antonella Santuccione Chadha

Dr. Antonella Santuccione Chadha

Co-founder and CEO, Women’s Brain Project
Head of stakeholder engagement for Alzheimer’s disease, Biogen

| KEYNOTE LECTURE

Sex and gender differences in brain and mental disease, the work of the Women’s Brain Project

Biography

Dr. Antonella Santuccione Chadha is a medical doctor with expertise in clinical pathology, neuroscience and psychiatric disorders. She is head of stakeholder engagement for Alzheimer’s disease at Biogen.  She is co-founder and CEO of the non-profit organization “Women’s Brain Project” which addresses the influence of sex and gender on mental and brain diseases. As a medical doctor, Antonella has decades of experience in preclinical research, patient treatment, clinical development, medical affairs and setting up the international regulatory framework for Alzheimer’s disease (AD).

Always focused on solving the puzzles related to Alzheimer’s and other psychiatric diseases, she studied possible immunotherapies for AD in the laboratory of Prof Roger Nitsch and Christoph Hock at the university of Zurich. She also worked with Swissmedic, Roche Diagnostics and Roche Pharma, several European universities, the EU Commission Directorate for Health and Food Safety, the OECD, the CEOi and several Alzheimer’s’ disease organizations.

Since 2018 she is listed among the top 100 Women in Business in Switzerland and in 2019, she was elected Woman of the Year in Switzerland by the Magazine “Women in Business”. In 2020, she received the World Sustainability Award for her involvement in advancing Precision Medicine. She also received the award “Premio Medicina Italia” for her contribution to the management of the pandemic.  In 2021 she was acknowledged among the “Women for Innovation” in Switzerland from the University of Basel. 

She is the Vice-president of Euresearch and acts as scientific advisor for several start-up and scientific institutions. She is the author of several scientific publications and books, among them “Una Bambina Senza Testa” and “Sex and Gender Differences in Alzheimer’s disease” published in 2021. Dr. Santuccione Chadha is keenly interested in removing bias when developing solutions for mental and neurological diseases to achieve precision medicines. 

Pre-event Speakers – Regulatory Session

Annalisa Macagno

Annalisa Macagno

Senior Project Manager, Quality Management and Regulatory Affairs, Effectum Medical

| PRE-EVENT WORKSHOP

IVDR Requirements for Diagnostic Products – in vitro tests, software, instruments

Biography

Annalisa has successfully established a QMS and transitioned IVD product development from research to market.

Rolf Kaufmann

Rolf Kaufmann

Senior Project Manager, Quality Management and Regulatory Affairs, Effectum Medical

| PRE-EVENT WORKSHOP

IVDR Requirements for Diagnostic Products – in vitro tests, software, instruments

Biography

Rolf is a physicist with a background in X-ray medical devices and regulatory affairs.

Speakers – Introductory Session

Falko Schlottig

Falko Schlottig

Biography

Prof. Dr. Falko Schlottig is Director School of Life Sciences at University of Applied Science and Arts Northwestern Switzerland (FHNW), Head of the Research Ressort FHNW and Standortleiter beider Basel.

He has long standing experience in research and product development and has held different management positions in internationally operating, leading medical device companies and start-ups. He is a member of different national scientific organisations.

Speakers – Medical/Clinical Session

Joan Montaner

Joan Montaner

Director of the Neurovascular Research Lab & Neurology Department at HVM, Seville. Coordinator of the Andalusian Healthcare Stroke Plan.

| CLINICAL SESSION

Stroke triage at the ambulance using POCT blood biomarkers

Abstract

Our laboratory work focuses on the identification of biomarkers to be used as diagnostic and prognostic tools in ischemic and hemorrhagic stroke and also as companion diagnostics for several stroke therapies. Several experimental models of cerebral ischemia allow our lab to do screening of potential neuroprotectant compounds to be used as future stroke therapies that might be administered based on biomarkers information.

In the talk I will show recent data on a rapid POCT to be used at the ambulances to differentiate ischemic from hemorrhagic stroke and to select those ischemic strokes due to Large Vessel Occlusion (LVO). That technology might be used in the future to start reperfusion therapies outside of the hospitals in acute ischemic stroke patients or to shift the LVO patient to thrombectomy centers. I will discuss which of these medical indications is closer to the clinics and try to identify some of the reasons of the translational failure in the field of stroke biomarkers and how to break those barriers in the near future.

Biography

Joan Montaner completed his studies in Medicine and Surgery at the Faculty of Medicine in Cadiz, Spain. He underwent specialty training in Neurology at the Hospital Vall d´Hebron in Barcelona. Dr. Montaner received his research training within the program at the Instituto de Salud Carlos III, part of which was performed at the Neuroprotection Research Laboratory of the Massachusetts General Hospital, Harvard University, Boston, MA, USA.

He created the Neurovascular Research Laboratory at Vall d´Hebron Neurovascular Unit in Barcelona in 2001 and he is the director of the Stroke Programme at IBIS-HVR, Sevilla, since 2013 where he also leads the Neurology Department at Macarena University Hospital. In 2018 he was appointed Coordinator of the Andalusian region Stroke Care Plan. His activities are reflected in the publication > 400 peer-reviewed articles (H index =81).

Dr. Montaner’s clinical and lab work focuses on the identification of biomarkers to be used as diagnostic and prognostic tools in brain damage and as companion diagnostics for several stroke therapies. Several experimental models of cerebral ischemia allow Montaner´s lab to do screening of potential compounds to be used as future stroke therapies.

 

Leslie Fendt

Leslie Fendt

PHC Integrated Solutions Product Leader, Roche

| CLINICAL SESSION

Remote vision monitoring – A case study 

Biography

Dr. Leslie Anne Fendt works at Roche leading the development and commercialization of one of Roche’s first Software-As-Medical-Device (SaMD) products, while simultaneously contributing to building out Roche’s overall digital health infrastructure, operating model, and strategy.

Previously at Roche she was leading the global commercialization of a novel immunology treatment, defining its go-to-market strategy and operationalizing the product launch worldwide. Before that, Leslie held a series of roles in sales, marketing, strategy, insights, and launch excellence both at global and affiliate level.

Leslie holds a Masters in Organic Chemistry with Minors in Business and Computer Science from Uni Basel, CH, and Cambridge, UK, and a PhD in Nanosciences from ETH Zurich. She is a board member of the Swiss Chemical Society and an active voice in the Digital Health/Tech community. Leslie lives with her partner, three daughters, and two cats in Switzerland.

 

Speakers – Research Session

Christophe Verjus

Christophe Verjus

Senior Project Manager, Project Office & Business Development Manager, Medtech at CSEM

| RESEARCH SESSION

Ava fertility tracker: wearable and AI for personalized health monitoring

Biography

Christophe Verjus leads the Project Office and Business Development for Digital Health at CSEM. He holds an Engineer degree in Physics from ESPCI Paris, and worked in the industry in Germany before joining CSEM in 2000. He has been active in the biomedical field for more than 20 years, both in hardware and data science, developing sensing technologies, wearables and medical systems for industrial partners and startups.

Alena Simalatsar

Alena Simalatsar

Professor UAS at the Institute of Systems Engineering, HES-SO Valais-Wallis

| RESEARCH SESSION

Control Strategies at the POC for Propofol Anesthesia Administration

Biography

Prof. Alena Simalatsar is a young tenure-track assistant professor at the Institute of Industrial Systems Engineering of the HES-SO Valais-Wallis in Sion, working in the domain of medical instrumentation.  She has received her Ph.D. in Electrical Engineering and Computer Science in 2009 from the University of Trento, Italy, and a Master’s degree from the Belarussian State University in Minsk, Belarus, both focusing on system-level analysis methodologies for embedded systems.

In the past 10 years, Prof. Simalatsar has been involved in several MedTech projects addressing the question of verification and trustworthy integration of medical devices conforming with system real-time and safety requirements. During these years she has developed a great experience in closed-loop drug delivery systems, autonomous microfluidics, and physiological signals acquisition and processing as well as experience in creation of a MedTech startup.

She is the author of more than 30 peer-reviewed publications in well-recognized journals and conference proceedings as well as two book chapters. In 2021, she has received a grant for DoAi-Vet as a Principal Investigator, the aim of which is to develop basic tools for EEG signal processing collected from pigs under anesthesia.